Home Hong Kong Sino Harbour Establishes New Subsidiary; Proposes to Tap Stem Cell Sector in… – Business News Asia
|
Home Hong Kong Sino Harbour Establishes New Subsidiary; Proposes to Tap Stem Cell Sector in…
Business News Asia Guangxi Gangrun is held by Zhejiang Sino Harbour Bio Technology Limited (“Zhejiang SH”), the Group's indirect wholly-owned subsidiary, together with Zhejiang Gene Stem Cell Biotech Company Limited (“Zhejiang GSCB”) and Mr. Mao Jianfeng in the … |
